Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

OHSU discovery could suggest new avenues to treat symptoms of Parkinson's disease

Researchers at Oregon Health & Science University have discovered that the neurotransmitter adenosine effectively acts as a brake to dopamine, another well-known neurotransmitter involved in motor control.

9 Nov 2022

Centuries-old mobility aids may be replaced by wearable exoskeletons

Exoskeletons -- motorized mechanical devices attached to an individual’s body to assist movement -- have been a popular feature in science fiction movies from Robocop to Iron Man as a means to give someone superhuman skills.

9 Nov 2022

Rheumatoid arthritis patients taking opioids have twice the risk of venous thromboembolism

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found that adult RA patients starting opioids had twice the risk of venous thromboembolism (VTE) compared to patients starting nonsteroidal anti-inflammatory drugs (NSAIDs).

8 Nov 2022

Study identifies a potential pharmacological target for treating COVID-19-associated heart failure

Researchers at the University of Maryland School of Medicine's (UMSOM) Center for Precision Disease Modeling identified how a specific protein in SARS-CoV-2, the virus responsible for COVID-19, damages heart tissue. They then used a drug to reverse the toxic effects of that protein on the heart.

8 Nov 2022

Restoring blood flow to the legs reduces pain, improves quality of life for people with peripheral artery disease

Restoring blood flow to the legs, whether through bypass surgery or a less invasive artery-opening procedure with a stent, reduced pain and improved quality of life for people with peripheral artery disease (PAD), according to preliminary, late-breaking research presented today at the American Heart Association's Scientific Sessions 2022.

7 Nov 2022

Mindfulness may offer a novel way to improve blood pressure control

A customized mindfulness program that taught participants to apply those skills to have healthy relationships with their diet, physical activity, alcohol use, medication adherence and stress, led to notably lower systolic (top number) blood pressure measures six months after participating in the mindfulness program, according to late-breaking science presented today at the American Heart Association's Scientific Sessions 2022.

7 Nov 2022

Administering steroids during heart surgery does not improve post-operative outcomes in infants

The largest clinical trial ever conducted in infants younger than age 1 undergoing heart surgery with cardiopulmonary bypass found that administering steroids during surgery did not improve post-operative outcomes compared to placebo, according to preliminary late-breaking research to be presented at the American Heart Association's Scientific Sessions 2022.

7 Nov 2022

Early use of ECMO devices to support adults with cardiogenic shock did not improve clinical outcomes

The immediate use of veno-arterial mechanical circulatory extracorporeal membrane oxygenation (ECMO) devices to support adults with rapidly deteriorating or severe cardiogenic shock was feasible but did not improve clinical outcomes compared to people who received early conservative therapy, according to late-breaking clinical trial results presented today at the American Heart Association's Scientific Sessions 2022.

7 Nov 2022

Dietary supplements taken for 'heart health' unlikely to offer meaningful impact on cholesterol levels

Six widely used dietary supplements promoted for improving heart health did not effectively lower LDL or "bad" cholesterol in comparison to a common low-dose statin medication or placebo, according to late breaking science results presented today at the American Heart Association's Scientific Sessions 2022.

7 Nov 2022

New medication lowers triglyceride levels, yet does not decrease cardiovascular risk in people with Type 2 diabetes

A new medication, pemafibrate, lowered triglyceride levels among adults with Type 2 diabetes yet did not decrease their cardiovascular risk, according to late-breaking science research presented today at the American Heart Association's Scientific Sessions 2022.

7 Nov 2022

National study sheds light on how to more effectively treat atrial fibrillation

A national study led by UBC researchers at the Centre for Cardiovascular Innovation is shedding light on how to more effectively treat atrial fibrillation (AF) – a common heart rhythm problem associated with increased risk of stroke and heart failure.

7 Nov 2022

Rosuvastatin vastly superior to six common heart health supplements

Six widely used dietary supplements often advertised to promote heart health are actually ineffective at lowering cholesterol levels.

7 Nov 2022

New analysis finds significant disparities in the treatment of familial hypercholesterolemia

The Family Heart Foundation, a leading research and advocacy organization, shared results from an analysis of its large U.S. Family Heart DatabaseTM showing significant disparities exist in the treatment of familial hypercholesterolemia (FH) among racial groups, and by income and education levels.

7 Nov 2022

Open bypass surgery results in better outcomes for specific patients with severe form of peripheral artery disease

Performing open bypass surgery to restore circulation for people with a severe form of peripheral artery disease (PAD) – a condition that limits blood flow to the legs and feet – resulted in better outcomes for specific patients compared to a less-invasive procedure, a National Institutes of Health-supported clinical research trial has found.

7 Nov 2022

New one-stop guideline takes a 360-degree approach to managing heart disease in Canadians

A new one-stop guideline takes a 360-degree approach to managing heart disease in Canadian patients, with 83 recommendations in one easy-to-use reference. The guideline is published in CMAJ (Canadian Medical Association Journal).

7 Nov 2022

Cannabis, cocaine, methamphetamine, and opiates increase risk of atrial fibrillation

A recent study published in the European Heart Journal reveals that using illicit drugs can increase atrial fibrillation risk.

6 Nov 2022

Study examines temporal effects of pre-existing CKD, other medical conditions on COVID-19 outcomes

Individuals with chronic kidney disease (CKD) are vulnerable to developing severe forms of COVID-19, and acute kidney injury is a common complication of COVID-19.

6 Nov 2022

Novel drug lowers triglycerides, does not reduce cardiovascular events

Levels of triglycerides are routinely measured as part of a preventive cardiology work-up and lowering triglycerides with several classes of drugs is common medical practice.

6 Nov 2022

Researchers use brain organoids to show how SARS-CoV-2 virus infects cortical neurons

Using human brain organoids, an international team of researchers, led by scientists at University of California San Diego School of Medicine and Sanford Consortium, has shown how the SARS-CoV-2 virus that causes COVID-19 infects cortical neurons and specifically destroys their synapses - the connections between brain cells that allow them to communicate with each other.

3 Nov 2022

Novel nasal cleansing system increases comfort and compliance in sleep apnea patients using CPAP

A novel nasal cleansing system (NasoClenzTM, Silicon Valley Innovations, Sunnyvale, CA) reduced bacterial colonization while increasing comfort and compliance in patients that use continuous positive airway pressure (CPAP) to treat sleep apnea, according to results of a clinical evaluation recently presented at the American College of Surgeons Clinical Congress.

3 Nov 2022

Stroke News and Research

Further Reading

OHSU discovery could suggest new avenues to treat symptoms of Parkinson's disease

Centuries-old mobility aids may be replaced by wearable exoskeletons

Rheumatoid arthritis patients taking opioids have twice the risk of venous thromboembolism

Study identifies a potential pharmacological target for treating COVID-19-associated heart failure

Restoring blood flow to the legs reduces pain, improves quality of life for people with peripheral artery disease

Mindfulness may offer a novel way to improve blood pressure control

Administering steroids during heart surgery does not improve post-operative outcomes in infants

Early use of ECMO devices to support adults with cardiogenic shock did not improve clinical outcomes

Dietary supplements taken for 'heart health' unlikely to offer meaningful impact on cholesterol levels

New medication lowers triglyceride levels, yet does not decrease cardiovascular risk in people with Type 2 diabetes

National study sheds light on how to more effectively treat atrial fibrillation

Rosuvastatin vastly superior to six common heart health supplements

New analysis finds significant disparities in the treatment of familial hypercholesterolemia

Open bypass surgery results in better outcomes for specific patients with severe form of peripheral artery disease

New one-stop guideline takes a 360-degree approach to managing heart disease in Canadians

Cannabis, cocaine, methamphetamine, and opiates increase risk of atrial fibrillation

Study examines temporal effects of pre-existing CKD, other medical conditions on COVID-19 outcomes

Novel drug lowers triglycerides, does not reduce cardiovascular events

Researchers use brain organoids to show how SARS-CoV-2 virus infects cortical neurons

Novel nasal cleansing system increases comfort and compliance in sleep apnea patients using CPAP

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News